Cargando…

Early termination of pivotal trials in Alzheimer's disease—Preserving optimal value for participants and science

Participants in Alzheimer's disease late‐phase clinical trials are frequently confronted with a situation of early termination. We discuss measures to protect the perceived value of study participation and to maximize the scientific value under such circumstances. A communication strategy shoul...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gietl, Anton F., Frisoni, Giovanni B.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2022
Materias:	Perspectives
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9790521/ https://www.ncbi.nlm.nih.gov/pubmed/35220681 http://dx.doi.org/10.1002/alz.12605

Ejemplares similares

Clinical application of CSF biomarkers for Alzheimer's disease: From rationale to ratios
por: Bouwman, Femke H., et al.
Publicado: (2022)

Not for industry only: medical students and office-based academic detailing the PIVOT (Pregnant women Influenza Vaccine Optimization Team) initiative
por: Blitz, Daina A, et al.
Publicado: (2015)

Understanding the Pivotal Role of the Vagus Nerve in Health from Pandemics
por: Rangon, Claire-Marie, et al.
Publicado: (2022)

Rapid Pivot of CURE Wet Lab to Online with the Help of Instructor Communities
por: González-Orta, Enid T., et al.
Publicado: (2022)

2022: a pivotal year for diagnosis and treatment of rare genetic diseases
por: Kingsmore, Stephen F.
Publicado: (2022)

Participant outcomes and preferences in Alzheimer's disease clinical trials: The electronic Person-Specific Outcome Measure (ePSOM) development program
por: Saunders, Stina, et al.
Publicado: (2018)

The Academy’s Pivotal Role in Supporting Public-Private Partnerships to Prevent Chronic Diseases
por: McRobbie, Michael A., et al.
Publicado: (2009)

Aberrant cell cycle induction is pivotal for mitochondrial biogenesis after traumatic brain injury
por: Sen, Nilkantha
Publicado: (2019)

Pivoting to a Remote-Learning Summer Student Program during the COVID-19 Pandemic
por: Berr, Alexandra L., et al.
Publicado: (2021)

On the horizon—the value and promise of the global pipeline of Alzheimer's disease therapeutics
por: Cole, Michael A., et al.
Publicado: (2020)

Supporting and leveraging science as a social activity: The value of sharing ideas early and often
por: Regehr, Glenn
Publicado: (2021)

An Integrated Approach for Assessing the Impact of Renal Impairment on Pharmacokinetics of Drugs in Development: Pivotal Role of PBPK Modelling
por: Rowland Yeo, Karen, et al.
Publicado: (2021)

Early Vision for the CTSA Program Trial Innovation Network: A Perspective from the National Center for Advancing Translational Sciences
por: Shah, MR, et al.
Publicado: (2017)

The importance of long-term follow up of participants in clinical trials
por: Cuzick, Jack
Publicado: (2022)

OxInflammation in Alzheimer’s disease
por: Cervellati, Carlo, et al.
Publicado: (2023)

On the value of preprints: An early career researcher perspective
por: Sarabipour, Sarvenaz, et al.
Publicado: (2019)

Open science challenges, benefits and tips in early career and beyond
por: Allen, Christopher, et al.
Publicado: (2019)

Physiologically‐Based Pharmacokinetic Models as Enablers of Precision Dosing in Drug Development: Pivotal Role of the Human Mass Balance Study
por: Rowland Yeo, Karen, et al.
Publicado: (2020)

Factors for optimizing intervention programs for cognition in older adults: the value of exergames
por: Perrot, Alexandra, et al.
Publicado: (2023)

Opportunities and counterintuitive challenges for decentralized clinical trials to broaden participant inclusion
por: Goodson, Noah, et al.
Publicado: (2022)

Pivotal role of Pharmacovigilance Programme of India in containment of antimicrobial resistance in India
por: Agrawal, Vijit, et al.
Publicado: (2019)

Progressive Hypoxia: A Pivotal Pathophysiologic Mechanism of COVID-19 Pneumonia
por: Somers, Virend K., et al.
Publicado: (2020)

The Longitudinal Early‐onset Alzheimer's Disease Study (LEADS): Framework and methodology
por: Apostolova, Liana G., et al.
Publicado: (2021)

Perspective: Council for Responsible Nutrition Science in Session. Optimizing Health with Nutrition—Opportunities, Gaps, and the Future
por: Ho, Emily, et al.
Publicado: (2023)

The hidden variables problem in Alzheimer's disease clinical trial design
por: Liyanage, S. Imindu, et al.
Publicado: (2018)

Alzheimer's disease in Down syndrome: An overlooked population for prevention trials
por: Strydom, André, et al.
Publicado: (2018)

Recruiting to preclinical Alzheimer's disease clinical trials through registries
por: Grill, Joshua D.
Publicado: (2017)

Mobile and pervasive computing technologies and the future of Alzheimer’s clinical trials
por: Doraiswamy, P. Murali, et al.
Publicado: (2018)

COVID-19 vaccine guidance for patients with cancer participating in oncology clinical trials
por: Desai, Aakash, et al.
Publicado: (2021)

The Pivotal Role of Prevention Science in This Syndemic
por: Fishbein, Diana
Publicado: (2020)

A pivotal role for HOXB7 protein in endocrine resistant breast cancer
por: Jin, Kideok, et al.
Publicado: (2015)

The Open Translational Science in Schizophrenia (OPTICS) project: an open-science project bringing together Janssen clinical trial and NIMH data
por: Wilcox, Marsha A., et al.
Publicado: (2018)

FDA position statement “Early Alzheimer's disease: Developing drugs for treatment, Guidance for Industry”
por: Sabbagh, Marwan N., et al.
Publicado: (2019)

Brain insulin resistance: an early risk factor for Alzheimer's disease development in Down syndrome
por: Barone, Eugenio
Publicado: (2021)

Retinal Examination Modalities in the Early Detection of Alzheimer's Disease: Seeing Brain Through the Eye
por: Ma, Xiaoxi, et al.
Publicado: (2022)

The Alzheimer's Prevention Initiative Generation Program: Study design of two randomized controlled trials for individuals at risk for clinical onset of Alzheimer's disease
por: Lopez Lopez, Cristina, et al.
Publicado: (2019)

Reflections on Participation in a Trial on Hydroxychloroquine as Prevention for COVID-19 among Health Workers in Niger
por: Kabore, Youssouf, et al.
Publicado: (2023)

Operationalizing selection criteria for clinical trials in Alzheimer's disease: Biomarker and clinical considerations
por: Petersen, Ronald C., et al.
Publicado: (2023)

The Value of Food Allergy Prevention in Clinical Practice in Pediatrics: Targeting Early Life
por: Anagnostou, Katherine, et al.
Publicado: (2018)

Genetically determined cardiomyopathies at autopsy: the pivotal role of the pathologist in establishing the diagnosis and guiding family screening
por: Sheppard, Mary N., et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_fd65dep6pql2244hbb38u0l97r